Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04090359
Other study ID # 17022801
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date September 1, 2017
Est. completion date October 1, 2034

Study information

Verified date June 2024
Source Rush University Medical Center
Contact Craig Della Valle, MD
Phone (312)432-2468
Email craig.dellavalle@rushortho.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.


Description:

The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 322
Est. completion date October 1, 2034
Est. primary completion date October 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Any patient older than 18 years of age scheduled for a revision THA, including revision of both components, conversion of a hip resurfacing to THA, conversion of a hemiarthroplasty to THA, and revision of single components which allow implantation of dual-mobility bearings. In addition, patients undergoing reimplantation of a total hip arthroplasty following a two-stage revision for periprosthetic infection will also be included. Only patients with an acetabular shell diameter capable of accommodating at least a 36mm femoral head will be included. Exclusion Criteria: - Less than 18 years of age, primary THA, - conversion of non-arthroplasty femoral neck fracture fixation to THA, - patients unwilling to participate. - patients where the surgeon makes the intraoperative decision to use a constrained liner will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dual Mobility Implant
Patients in this intervention will receive a dual mobility implant
Conventional, single-bearing implant
Patients in this intervention will receive a conventional, single-bearing implant

Locations

Country Name City State
United States New York University Medical Center New York New York
United States Rothman Institute Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
Rush University Medical Center NYU Langone Health, Rothman Institute Orthopaedics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 6 weeks
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 3 months
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 2 years
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 5 years
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 10 years
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 15 years
Primary Prosthetic Dislocation The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits 20 years
Secondary Complications Any peri- or postoperative complications will be recorded, including component loosening, occurrence of intraprosthetic dislocation, infection, periprosthetic fractures, revision rates up to 20 years after the patient is discharged from the hospital
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 6 weeks
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 3 months
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 2 years
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 5 years
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 10 years
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 15 years
Secondary Routine radiographs assess for loosening and proper component placement Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way. 20 years.
See also
  Status Clinical Trial Phase
Recruiting NCT04092634 - Dual Mobility in "High Risk" Patients Phase 4
Enrolling by invitation NCT05587244 - G7 Freedom Constrained Vivacit-E Liners N/A
Enrolling by invitation NCT05548972 - G7 Dual Mobility With Vivacit-E or Longevity PMCF N/A
Not yet recruiting NCT04685239 - Dual Mobility Cup Versus Unipolar Cup N/A